Skip to content 
Search

Latest Stories

UK starts hydroxychloroquine trials, studying the drug 'with great care'

BRITISH healthcare workers have on Thursday (21) started taking part in a University of Oxford-led international trial of two anti-malarial drugs against Covid-19, including one US President Donald Trump says he has been taking.

The 'COPCOV' study will involve more than 40,000 frontline healthcare workers from Europe, Africa, Asia and South America to determine if chloroquine and hydroxychloroquine are effective in preventing the novel coronavirus.


The drugs have risen to prominence since Trump said earlier this week he was taking hydroxychloroquine as a preventive medicine against the virus despite medical warnings about its use.

The trial, led by the University of Oxford with the support of the Mahidol Oxford Tropical Medicine Research Unit (MORU) in Bangkok, will open to British participants at hospital sites in Brighton and Oxford on Thursday and involve those who are in close contact with patients with proven or suspected Covid-19.

"We really do not know if chloroquine or hydroxychloroquine are beneficial or harmful against Covid-19," said the University of Oxford's Professor Nicholas White, the study's co-principal investigator who is based at MORU.

"The best way to find out if they are effective in preventing Covid-19 is in a randomised clinical trial."

In Britain, Europe and Africa participants will receive either hydroxychloroquine or a placebo for three months. In Asia they will receive either chloroquine or a placebo.

A total of 25 study sites are expected to be open in the UK by the end of June, MORU said, with plans for further sites in Thailand and Southeast Asia, Italy, Portugal, Africa and South America. The results are expected by the end of this year.

"We are looking at this with great care and examining all of the evidence that is out there," Security Minister James Brokenshire told Sky News.

Trump's defence pill

Earlier this week, Donald Trump said he had been taking the much-talked-about anti-malarial drug to ward off the conronavirus.

"I'm taking hydroxychloroquine," said the US president. "I've been taking it for the last week and a half. A pill every day."

“I take it because I think I hear very good things.

To queries on warnings about its possible side effects, Trump replied: "People are going to have to make up their own mind. I think it gives you an additional level of safety.

"I think it's worth it as a line of defence and I'll stay on it for a little while longer.

"It's gotten a bad reputation only because I'm promoting it."

The Right-wing thing

Brazilian President Jair Bolsonaro neatly summed up how politics had hijacked the debate over using malaria drugs against the new coronavirus: "Right-wingers take chloroquine."

The far-right leader made the remark on Tuesday, a day before his government recommended widespread use of chloroquine and a less-toxic derivative, hydroxychloroquine, to treat Covid-19 even in mild cases, despite questions about their safety and effectiveness.

"There is still no scientific proof, but (chloroquine) is being monitored and used in Brazil and around the world," Bolsonaro tweeted on Wednesday.

"We are at war. Worse than defeat is the shame of never having fought at all."

The Brazilian health ministry acknowledged that "there are still no meta-analyses of randomized, controlled, blind, large-scale clinical trials of these medications in the treatment of Covid-19".

However, it said the government had a responsibility to issue guidelines using the information currently available.

"Brazilians are asking to receive this medication, which has shown positive results in various clinical studies. And we need to give them that right, even if the number of studies is still scarce," health ministry official Mayra Pinheiro told a news conference.

More For You

Human brain continues forming neurons

Neurogenesis, the process by which new neurons form in the brain

iStock

Human brain continues forming neurons well into old age, study finds

Key points

  • New neurons continue forming in the brain’s hippocampus into old age
  • Study confirms presence of neural progenitor cells in adults
  • DNA carbon dating and single-nucleus RNA sequencing were used
  • Research shows variation in neuron production between individuals
  • Findings could aid treatments for neurodegenerative and psychiatric disorders

Human brain shows ongoing neuron formation into older age

A new study has confirmed that the human brain continues to produce new nerve cells well into late adulthood, challenging previous assumptions about age-related decline in neurogenesis. The findings, published in the journal Science, provide fresh insight into how adaptable the brain remains over a lifetime.

Neurogenesis, the process by which new neurons form in the brain, is known to occur in the hippocampus — a region involved in memory. While previous research has suggested that this process continues throughout life, there has been limited concrete evidence of the presence of neural progenitor cells in the adult brain.

Keep ReadingShow less
Kent County Show 2025

Sophie, Duchess of Edinburgh, who grew up in Brenchley

Getty Images

Kent County Show opens with royal visit from Duchess of Edinburgh

Key points:

  • Day one of the Kent County Show begins at Detling Showground near Maidstone
  • The Duchess of Edinburgh visits the event for the first time in 16 years
  • Organisers expect up to 70,000 visitors over the weekend
  • Farming and rural life are at the centre of the three-day programme
  • Highlights include live camel racing, equine sports, livestock displays and more

Kent County Show opens with royal visit

The Kent County Show returned to Detling near Maidstone on Friday, marking the start of a major three-day celebration of farming, food, and rural living. The event opened with a special visit from the Duchess of Edinburgh, who is attending for the first time in 16 years.

Sophie, Duchess of Edinburgh, who grew up in Brenchley near Tunbridge Wells and serves as patron of the Association of Show and Agricultural Organisations (ASAO), met with farmers, equine exhibitors, and local businesses on her tour of the showground.

Keep ReadingShow less
Sri Aurobindo

Heehs’s biography is grounded in extensive archival research across France, England, India and Israel

AMG

Sri Aurobindo and the rise of the Asian century

Dinesh Sharma

My friend and colleague, the American historian Peter Heehs, who has lived in Pondicherry, India, for decades, recently published a compelling new biography, The Mother: A Life of Sri Aurobindo’s Collaborator (2025). Heehs previously authored The Lives of Sri Aurobindo (2008), which remains one of the most balanced and scholarly accounts of Aurobindo’s life.

According to Heehs, most previous biographies of the Mother were written for devotees and relied on secondary sources, often presenting her as a divine incarnation without critical engagement. “Such biographies are fine for those who see the Mother as a divine being,” Heehs said, “but they can be off-putting for readers who simply want to understand her life – as an artist, writer, spiritual teacher, and founder of the Ashram and Auroville.”

Keep ReadingShow less
Black women cancer risk

Serious public health challenges in the decades ahead

iStock

Study warns of rising uterine cancer rates, with Black women hardest hit

Key points

  • Uterine cancer cases and deaths are projected to rise significantly in the US by 2050.
  • Black women are expected to experience the highest increase in incidence-based mortality.
  • A new model predicts incidence rising to 86.9 cases per 100,000 for Black women and 74.2 for White women.
  • Researchers stress the urgent need for improved prevention and early detection strategies.

Sharp increase in uterine cancer predicted over next three decades

Uterine cancer, currently the fourth most commonly diagnosed cancer among women in the United States, is projected to see a substantial rise in both cases and deaths by 2050, particularly among Black women. A new study led by researchers at Columbia University warns of worsening racial disparities in outcomes if preventative measures are not introduced.

This year alone, around 69,120 new cases of uterine cancer and nearly 14,000 deaths are expected in the United States. However, projections by the Columbia University research team, published in Cancer Epidemiology, Biomarkers & Prevention, indicate a significant increase in both incidence and mortality over the next 30 years.

Keep ReadingShow less
Tesco Scotch Egg recall

Tesco has issued an urgent product recall for two batches of Wall’s Scotch Eggs

Tesco

Tesco recalls Wall’s Scotch Eggs over salmonella contamination

Key points

  • Tesco and the Food Standards Agency (FSA) have issued an urgent recall for Wall’s Scotch Eggs.
  • Salmonella contamination has been confirmed in two batches with a use-by date of July 2, 2025.
  • Customers are advised not to eat the affected items and return them to any Tesco store for a full refund.
  • No other Wall’s products are affected by this recall.

Wall’s Scotch Eggs recalled due to salmonella risk

Tesco has issued an urgent product recall for two batches of Wall’s Scotch Eggs after salmonella contamination was confirmed. The Food Standards Agency (FSA) supported the decision and has advised customers to check their kitchens and dispose of or return the products immediately.

The recall applies specifically to Wall’s 2 Classic Scotch Eggs 226g and Wall’s The Classic Scotch Egg 113g, both with a use-by date of 2 July 2025. Customers who purchased either product are urged not to consume them due to the potential health risk.

Keep ReadingShow less